A detailed history of Stifel Financial Corp transactions in Zoetis Inc. stock. As of the latest transaction made, Stifel Financial Corp holds 715,124 shares of ZTS stock, worth $122 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
715,124
Previous 697,913 2.47%
Holding current value
$122 Million
Previous $121 Million 15.48%
% of portfolio
0.15%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$172.58 - $196.48 $2.97 Million - $3.38 Million
17,211 Added 2.47%
715,124 $140 Million
Q2 2024

Aug 13, 2024

SELL
$145.54 - $178.83 $25.6 Million - $31.5 Million
-176,133 Reduced 20.15%
697,913 $121 Million
Q1 2024

May 13, 2024

BUY
$165.67 - $199.94 $9.35 Million - $11.3 Million
56,432 Added 6.9%
874,046 $148 Million
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $10.5 Million - $13.9 Million
69,223 Added 9.25%
817,614 $161 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $8.77 Million - $10.1 Million
52,448 Added 7.54%
748,391 $130 Million
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $25.4 Million - $29.4 Million
157,749 Added 29.31%
695,943 $120 Million
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $17.9 Million - $21.6 Million
123,229 Added 29.7%
538,194 $89.6 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $729,794 - $876,320
5,565 Added 1.36%
414,965 $60.8 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $1.58 Million - $1.95 Million
10,675 Added 2.68%
409,400 $60.7 Million
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $283,085 - $363,163
-1,815 Reduced 0.45%
398,725 $68.5 Million
Q1 2022

May 13, 2022

BUY
$181.39 - $234.03 $1.72 Million - $2.22 Million
9,491 Added 2.43%
400,540 $75.5 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $1.81 Million - $2.3 Million
9,322 Added 2.44%
391,049 $95.4 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $95,212 - $105,474
503 Added 0.13%
381,727 $74.1 Million
Q2 2021

Aug 13, 2021

SELL
$155.9 - $187.99 $5.8 Million - $7 Million
-37,232 Reduced 8.9%
381,224 $71 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $3.57 Million - $4.2 Million
24,796 Added 6.3%
418,456 $65.9 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $2.93 Million - $3.26 Million
18,678 Added 4.98%
393,660 $65.2 Million
Q3 2020

Nov 16, 2020

BUY
$137.1 - $165.37 $6.47 Million - $7.81 Million
47,225 Added 14.41%
374,982 $62 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $2.61 Million - $3.33 Million
23,363 Added 7.68%
327,757 $44.9 Million
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $10.4 Million - $16.3 Million
-112,133 Reduced 26.92%
304,394 $35.8 Million
Q4 2019

Feb 13, 2020

BUY
$116.25 - $133.25 $1.58 Million - $1.81 Million
13,620 Added 3.38%
416,527 $55.1 Million
Q3 2019

Nov 19, 2019

SELL
$112.57 - $128.43 $21,951 - $25,043
-195 Reduced 0.05%
402,907 $49.9 Million
Q3 2019

Nov 13, 2019

BUY
$112.57 - $128.43 $1.89 Million - $2.16 Million
16,781 Added 4.34%
403,102 $50 Million
Q2 2019

Aug 14, 2019

BUY
$97.98 - $114.28 $4.57 Million - $5.33 Million
46,676 Added 13.74%
386,321 $43.8 Million
Q1 2019

May 14, 2019

BUY
$81.56 - $100.67 $11.9 Million - $14.7 Million
146,364 Added 75.73%
339,645 $34.2 Million
Q4 2018

Feb 13, 2019

SELL
$79.28 - $95.27 $133,348 - $160,244
-1,682 Reduced 0.86%
193,281 $16.5 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $1.99 Million - $2.22 Million
-23,854 Reduced 10.9%
194,963 $17.8 Million
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $446,720 - $498,717
-5,591 Reduced 2.49%
218,817 $18.6 Million
Q1 2018

May 11, 2018

BUY
$71.51 - $84.69 $627,643 - $743,324
8,777 Added 4.07%
224,408 $18.8 Million
Q4 2017

Feb 14, 2018

BUY
$63.24 - $72.8 $244,928 - $281,954
3,873 Added 1.83%
215,631 $15.5 Million
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $12.6 Million - $13.8 Million
211,758
211,758 $0

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $80B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.